Loading…

The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma

In pancreatic cancer, imaging plays an essential role in surveillance, diagnosis, resectability evaluation, and treatment response evaluation. Pancreatic cancer surveillance in high-risk individuals has been attempted using endoscopic ultrasound (EUS) or magnetic resonance imaging (MRI). Imaging dia...

Full description

Saved in:
Bibliographic Details
Published in:Korean journal of radiology 2021, 22(1), , pp.23-40
Main Authors: Rhee, Hyungjin, Park, Mi Suk
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c449t-2696d862c9777031ba070af905849bdc9ef080342ab21e48fa10b9885a8392243
cites cdi_FETCH-LOGICAL-c449t-2696d862c9777031ba070af905849bdc9ef080342ab21e48fa10b9885a8392243
container_end_page 40
container_issue 1
container_start_page 23
container_title Korean journal of radiology
container_volume 22
creator Rhee, Hyungjin
Park, Mi Suk
description In pancreatic cancer, imaging plays an essential role in surveillance, diagnosis, resectability evaluation, and treatment response evaluation. Pancreatic cancer surveillance in high-risk individuals has been attempted using endoscopic ultrasound (EUS) or magnetic resonance imaging (MRI). Imaging diagnosis and resectability evaluation are the most important factors influencing treatment decisions, where computed tomography (CT) is the preferred modality. EUS, MRI, and positron emission tomography play a complementary role to CT. Treatment response evaluation is of increasing clinical importance, especially in patients undergoing neoadjuvant therapy. This review aimed to comprehensively review the role of imaging in relation to the current treatment strategy for pancreatic cancer, including surveillance, diagnosis, evaluation of resectability and treatment response, and prediction of prognosis.
doi_str_mv 10.3348/kjr.2019.0862
format article
fullrecord <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_9626420</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2441286040</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-2696d862c9777031ba070af905849bdc9ef080342ab21e48fa10b9885a8392243</originalsourceid><addsrcrecordid>eNpdkUFv1DAQhS0EokvhyBVZ4gKHLOOxk9gXpNWKwkqVgLKcLcfrbL2b2K2TIPHv63RLBZxmpPn8_GYeIa8ZLDkX8sPxkJYITC1BVviELBCgLCTn8JQsGKIqKoXqjLwYhgMAKpDiOTnjuWGilAvyfXvt6FXsHI0t3fRm78Oe-kDXU0oujHSbnBn7ufsxJjO6vXcDbWOi30yw88xbutq5EK1J1ofYm5fkWWu6wb16qOfk58Wn7fpLcfn182a9uiysEGossFLVLlu2qq5r4KwxUINpFZRSqGZnlWtBAhdoGmROyNYwaJSUpZFcIQp-Tt6fdENq9dF6HY2_r_uoj0mvrrYbrSqsBEJmP57Ym6np3c7mfZLp9E3yvUm_71_-Own-Ouv80tkbcsmywLsHgRRvJzeMuveDdV1ngovToFEIhrICMf_19j_0EKcU8ik01iihLLmoMlWcKJviMCTXPpphoOdgdQ5Wz8HqOdjMv_l7g0f6T5L8DlRKnP8</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2728055346</pqid></control><display><type>article</type><title>The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Rhee, Hyungjin ; Park, Mi Suk</creator><creatorcontrib>Rhee, Hyungjin ; Park, Mi Suk</creatorcontrib><description>In pancreatic cancer, imaging plays an essential role in surveillance, diagnosis, resectability evaluation, and treatment response evaluation. Pancreatic cancer surveillance in high-risk individuals has been attempted using endoscopic ultrasound (EUS) or magnetic resonance imaging (MRI). Imaging diagnosis and resectability evaluation are the most important factors influencing treatment decisions, where computed tomography (CT) is the preferred modality. EUS, MRI, and positron emission tomography play a complementary role to CT. Treatment response evaluation is of increasing clinical importance, especially in patients undergoing neoadjuvant therapy. This review aimed to comprehensively review the role of imaging in relation to the current treatment strategy for pancreatic cancer, including surveillance, diagnosis, evaluation of resectability and treatment response, and prediction of prognosis.</description><identifier>ISSN: 1229-6929</identifier><identifier>EISSN: 2005-8330</identifier><identifier>DOI: 10.3348/kjr.2019.0862</identifier><identifier>PMID: 32901458</identifier><language>eng</language><publisher>Korea (South): The Korean Society of Radiology</publisher><subject>Adenocarcinoma - diagnostic imaging ; Adenocarcinoma - pathology ; Adenocarcinoma - therapy ; Asymptomatic ; Bile ducts ; Cancer therapies ; Chemotherapy ; Endoscopy ; Gastrointestinal Imaging ; Humans ; Lymphatic system ; Magnetic Resonance Imaging ; Metastasis ; Neoadjuvant Therapy ; Neoplasm Staging ; Pancreatic cancer ; Pancreatic Neoplasms - diagnostic imaging ; Pancreatic Neoplasms - pathology ; Pancreatic Neoplasms - therapy ; Positron-Emission Tomography ; Prognosis ; Radiation therapy ; Surveillance ; Tomography ; Tomography, X-Ray Computed ; Tumors ; Ultrasonic imaging ; Ultrasonography ; 방사선과학</subject><ispartof>Korean Journal of Radiology, 2021, 22(1), , pp.23-40</ispartof><rights>Copyright © 2021 The Korean Society of Radiology.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2021 The Korean Society of Radiology 2021 The Korean Society of Radiology</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c449t-2696d862c9777031ba070af905849bdc9ef080342ab21e48fa10b9885a8392243</citedby><cites>FETCH-LOGICAL-c449t-2696d862c9777031ba070af905849bdc9ef080342ab21e48fa10b9885a8392243</cites><orcidid>0000-0001-7759-4458 ; 0000-0001-5817-2444</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2728055346/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2728055346?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32901458$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002659363$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Rhee, Hyungjin</creatorcontrib><creatorcontrib>Park, Mi Suk</creatorcontrib><title>The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma</title><title>Korean journal of radiology</title><addtitle>Korean J Radiol</addtitle><description>In pancreatic cancer, imaging plays an essential role in surveillance, diagnosis, resectability evaluation, and treatment response evaluation. Pancreatic cancer surveillance in high-risk individuals has been attempted using endoscopic ultrasound (EUS) or magnetic resonance imaging (MRI). Imaging diagnosis and resectability evaluation are the most important factors influencing treatment decisions, where computed tomography (CT) is the preferred modality. EUS, MRI, and positron emission tomography play a complementary role to CT. Treatment response evaluation is of increasing clinical importance, especially in patients undergoing neoadjuvant therapy. This review aimed to comprehensively review the role of imaging in relation to the current treatment strategy for pancreatic cancer, including surveillance, diagnosis, evaluation of resectability and treatment response, and prediction of prognosis.</description><subject>Adenocarcinoma - diagnostic imaging</subject><subject>Adenocarcinoma - pathology</subject><subject>Adenocarcinoma - therapy</subject><subject>Asymptomatic</subject><subject>Bile ducts</subject><subject>Cancer therapies</subject><subject>Chemotherapy</subject><subject>Endoscopy</subject><subject>Gastrointestinal Imaging</subject><subject>Humans</subject><subject>Lymphatic system</subject><subject>Magnetic Resonance Imaging</subject><subject>Metastasis</subject><subject>Neoadjuvant Therapy</subject><subject>Neoplasm Staging</subject><subject>Pancreatic cancer</subject><subject>Pancreatic Neoplasms - diagnostic imaging</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Pancreatic Neoplasms - therapy</subject><subject>Positron-Emission Tomography</subject><subject>Prognosis</subject><subject>Radiation therapy</subject><subject>Surveillance</subject><subject>Tomography</subject><subject>Tomography, X-Ray Computed</subject><subject>Tumors</subject><subject>Ultrasonic imaging</subject><subject>Ultrasonography</subject><subject>방사선과학</subject><issn>1229-6929</issn><issn>2005-8330</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkUFv1DAQhS0EokvhyBVZ4gKHLOOxk9gXpNWKwkqVgLKcLcfrbL2b2K2TIPHv63RLBZxmpPn8_GYeIa8ZLDkX8sPxkJYITC1BVviELBCgLCTn8JQsGKIqKoXqjLwYhgMAKpDiOTnjuWGilAvyfXvt6FXsHI0t3fRm78Oe-kDXU0oujHSbnBn7ufsxJjO6vXcDbWOi30yw88xbutq5EK1J1ofYm5fkWWu6wb16qOfk58Wn7fpLcfn182a9uiysEGossFLVLlu2qq5r4KwxUINpFZRSqGZnlWtBAhdoGmROyNYwaJSUpZFcIQp-Tt6fdENq9dF6HY2_r_uoj0mvrrYbrSqsBEJmP57Ym6np3c7mfZLp9E3yvUm_71_-Own-Ouv80tkbcsmywLsHgRRvJzeMuveDdV1ngovToFEIhrICMf_19j_0EKcU8ik01iihLLmoMlWcKJviMCTXPpphoOdgdQ5Wz8HqOdjMv_l7g0f6T5L8DlRKnP8</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Rhee, Hyungjin</creator><creator>Park, Mi Suk</creator><general>The Korean Society of Radiology</general><general>대한영상의학회</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope><orcidid>https://orcid.org/0000-0001-7759-4458</orcidid><orcidid>https://orcid.org/0000-0001-5817-2444</orcidid></search><sort><creationdate>20210101</creationdate><title>The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma</title><author>Rhee, Hyungjin ; Park, Mi Suk</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-2696d862c9777031ba070af905849bdc9ef080342ab21e48fa10b9885a8392243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adenocarcinoma - diagnostic imaging</topic><topic>Adenocarcinoma - pathology</topic><topic>Adenocarcinoma - therapy</topic><topic>Asymptomatic</topic><topic>Bile ducts</topic><topic>Cancer therapies</topic><topic>Chemotherapy</topic><topic>Endoscopy</topic><topic>Gastrointestinal Imaging</topic><topic>Humans</topic><topic>Lymphatic system</topic><topic>Magnetic Resonance Imaging</topic><topic>Metastasis</topic><topic>Neoadjuvant Therapy</topic><topic>Neoplasm Staging</topic><topic>Pancreatic cancer</topic><topic>Pancreatic Neoplasms - diagnostic imaging</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Pancreatic Neoplasms - therapy</topic><topic>Positron-Emission Tomography</topic><topic>Prognosis</topic><topic>Radiation therapy</topic><topic>Surveillance</topic><topic>Tomography</topic><topic>Tomography, X-Ray Computed</topic><topic>Tumors</topic><topic>Ultrasonic imaging</topic><topic>Ultrasonography</topic><topic>방사선과학</topic><toplevel>online_resources</toplevel><creatorcontrib>Rhee, Hyungjin</creatorcontrib><creatorcontrib>Park, Mi Suk</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Korean journal of radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rhee, Hyungjin</au><au>Park, Mi Suk</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma</atitle><jtitle>Korean journal of radiology</jtitle><addtitle>Korean J Radiol</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>22</volume><issue>1</issue><spage>23</spage><epage>40</epage><pages>23-40</pages><issn>1229-6929</issn><eissn>2005-8330</eissn><abstract>In pancreatic cancer, imaging plays an essential role in surveillance, diagnosis, resectability evaluation, and treatment response evaluation. Pancreatic cancer surveillance in high-risk individuals has been attempted using endoscopic ultrasound (EUS) or magnetic resonance imaging (MRI). Imaging diagnosis and resectability evaluation are the most important factors influencing treatment decisions, where computed tomography (CT) is the preferred modality. EUS, MRI, and positron emission tomography play a complementary role to CT. Treatment response evaluation is of increasing clinical importance, especially in patients undergoing neoadjuvant therapy. This review aimed to comprehensively review the role of imaging in relation to the current treatment strategy for pancreatic cancer, including surveillance, diagnosis, evaluation of resectability and treatment response, and prediction of prognosis.</abstract><cop>Korea (South)</cop><pub>The Korean Society of Radiology</pub><pmid>32901458</pmid><doi>10.3348/kjr.2019.0862</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0001-7759-4458</orcidid><orcidid>https://orcid.org/0000-0001-5817-2444</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1229-6929
ispartof Korean Journal of Radiology, 2021, 22(1), , pp.23-40
issn 1229-6929
2005-8330
language eng
recordid cdi_nrf_kci_oai_kci_go_kr_ARTI_9626420
source Publicly Available Content Database; PubMed Central
subjects Adenocarcinoma - diagnostic imaging
Adenocarcinoma - pathology
Adenocarcinoma - therapy
Asymptomatic
Bile ducts
Cancer therapies
Chemotherapy
Endoscopy
Gastrointestinal Imaging
Humans
Lymphatic system
Magnetic Resonance Imaging
Metastasis
Neoadjuvant Therapy
Neoplasm Staging
Pancreatic cancer
Pancreatic Neoplasms - diagnostic imaging
Pancreatic Neoplasms - pathology
Pancreatic Neoplasms - therapy
Positron-Emission Tomography
Prognosis
Radiation therapy
Surveillance
Tomography
Tomography, X-Ray Computed
Tumors
Ultrasonic imaging
Ultrasonography
방사선과학
title The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T22%3A25%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20Imaging%20in%20Current%20Treatment%20Strategies%20for%20Pancreatic%20Adenocarcinoma&rft.jtitle=Korean%20journal%20of%20radiology&rft.au=Rhee,%20Hyungjin&rft.date=2021-01-01&rft.volume=22&rft.issue=1&rft.spage=23&rft.epage=40&rft.pages=23-40&rft.issn=1229-6929&rft.eissn=2005-8330&rft_id=info:doi/10.3348/kjr.2019.0862&rft_dat=%3Cproquest_nrf_k%3E2441286040%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c449t-2696d862c9777031ba070af905849bdc9ef080342ab21e48fa10b9885a8392243%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2728055346&rft_id=info:pmid/32901458&rfr_iscdi=true